A review of the expenditure on research and development in the books of several top domestic and multinational drug makers shows this includes cost incurred on generic development, regulatory......
MNCs increasingly turning to emerging destinations in Southeast Asia due to clearer set of procedures, approvals.In 2000, it was projected as the next big thing to happen in healthcare, for its......
Leading Indian drug companies such as Dr Reddy's Laboratories, Sun Pharma, Glenmarkand Lupin are now in a transformation mode, from traditional family-run businesses to corporations run by......
Piramal Healthcare's drug discovery arm, Piramal Life Sciences Ltd, is planning to move at least three more novel chemical entities under development into the human clinical trial stage within the......
Glenmark Pharmaceuticals, India's 11th biggest drug maker by sales, may beat bigger rivals, including Ranbaxy, Dr Reddy's and Nicholas Piramal, in selling an original drug, or novel chemical......